Brief: Evoke Pharma - In Accordance With Nasdaq Listing Rule 5810(C)(3)(A), Co Has Been Provided Initial Period Of 180 Calendar Days To Regain Compliance

Evoke Pharma

23/02/2024 23:45

Feb 23 (Reuters) - Evoke Pharma Inc  EVOK.O :
    * EVOKE PHARMA - IN ACCORDANCE WITH NASDAQ LISTING RULE
5810(C)(3)(A), CO HAS BEEN PROVIDED INITIAL PERIOD OF 180
CALENDAR DAYS TO REGAIN COMPLIANCE

Source text for Eikon:  ID:n0000950170-24-019381 
Further company coverage:  EVOK.O 

 ((reuters.briefs@thomsonreuters.com;))